Skip to main content

Table 1 Patients’ clinical profiles

From: Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age

   < 80 years old  ≥ 80 years old P value
(n = 146) (n = 101)
Age (years) 67.5 ± 10.0 85.1 ± 3.7 < 0.001
Male (n, %) 94, 64.4 48, 47.5 < 0.001
Height (cm) 160.5 ± 9.0 154.9 ± 8.6 < 0.001
Weight (kg) 56.5 ± 13.5 46.9 ± 9.5 < 0.001
Body mass index (kg/m2) 21.8 ± 4.1 19.5 ± 3.4 < 0.001
NYHA class (II/III/IV) 1/122/23 1/88/12 0.376
CS class (I/II/III) 48/83/15 25/66/10 0.270
Hypertension (n, %) 112, 76.7 82, 81.2 0.402
Diabetes mellitus (n, %) 37, 25.3 23, 22.8 0.645
Dyslipidemia (n, %) 29, 19.9 26, 25.7 0.277
Chronic kidney disease (n, %) 18, 12.3 20, 19.8 0.110
Prior HF hospitalization (n, %) 54, 37.0 45, 44.6 0.234
  1. NYHA: New York Heart Association, CS: clinical scenario, HF: heart failure. Continuous data are expressed as the mean ± standard deviation or error. P-values were determined using the unpaired t-test